Interleukin 10 receptor blockade: pentavalent antimony treatment in experimental visceral leishmaniasisMURRAY, Henry W.Acta tropica. 2005, Vol 93, Num 3, pp 295-301, issn 0001-706X, 7 p.Article

Treatment of visceral leishmaniasis in 2004MURRAY, Henry W.The American journal of tropical medicine and hygiene. 2004, Vol 71, Num 6, pp 787-794, issn 0002-9637, 8 p.Article

Suppression of posttreatment recurrence of experimental visceral leishmaniasis in T-cell-deficient mice by oral miltefosineMURRAY, Henry W.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 11, pp 3235-3236, issn 0066-4804Article

Review: Leishmaniasis in the United States: Treatment in 2012MURRAY, Henry W.The American journal of tropical medicine and hygiene. 2012, Vol 86, Num 3, pp 434-440, issn 0002-9637, 7 p.Article

Accelerated Control of Visceral Leishmania donovani Infection in Interleukin-6-Deficient MiceMURRAY, Henry W.Infection and immunity. 2008, Vol 76, Num 9, pp 4088-4091, issn 0019-9567, 4 p.Article

Clinical and experimental advances in treatment of visceral LeishmaniasisMURRAY, Henry W.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 8, pp 2185-2197, issn 0066-4804Article

Tissue granuloma structure-function in expérimental visceral leishmaniasisMURRAY, Henry W.International journal of experimental pathology. 2001, Vol 82, Num 5, pp 249-267, issn 0959-9673Article

Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis : Intracellular adhesion molecule 1-dependent and -independent regulationMURRAY, Henry W.Infection and immunity. 2000, Vol 68, Num 11, pp 6294-6299, issn 0019-9567Article

Treatment of visceral Leishmaniasis (Kala-Azar) : A decade of progress and future approachesMURRAY, Henry W.International journal of infectious diseases. 2000, Vol 4, Num 3, pp 158-177, issn 1201-9712Article

Availability of miltefosine for the treatment of kala-azar in IndiaSUNDAR, Shyam; MURRAY, Henry W.Bulletin of the World Health Organization. 2005, Vol 83, Num 5, pp 394-395, issn 0042-9686, 2 p.Article

Malaria: 30 years of experience at a New York City teaching hospitalKAMBILI, Chrispin; MURRAY, Henry W; GOLIGHTLY, Linnie M et al.The American journal of tropical medicine and hygiene. 2004, Vol 70, Num 4, pp 408-411, issn 0002-9637, 4 p.Article

Short report : Responses to Leishmania Donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthaseMURRAY, Henry W; ZHAOYING XIANG; XIAOJING MA et al.The American journal of tropical medicine and hygiene. 2006, Vol 74, Num 6, pp 1013-1015, issn 0002-9637, 3 p.Article

Drugs against leishmaniasis: a synergy of technology and partnershipsDAVIS, Antony J; MURRAY, Henry W; HANDMAN, Emanuela et al.Trends in parasitology. 2004, Vol 20, Num 2, pp 73-76, issn 1471-4922, 4 p.Article

Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18MURRAY, Henry W; TSAI, Christine W; JIANGUO LIU et al.Infection and immunity. 2006, Vol 74, Num 7, pp 4370-4374, issn 0019-9567, 5 p.Article

Visceral Leishmania donovani infection in interleukin-13^-/- miceMURRAY, Henry W; TSAI, Christine W; JIANGUO LIU et al.Infection and immunity. 2006, Vol 74, Num 4, pp 2487-2490, issn 0019-9567, 4 p.Article

Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasisMURRAY, Henry W; MONTELIBANO, Christina; PETERSON, Ron et al.The Journal of infectious diseases. 2000, Vol 182, Num 5, pp 1497-1502, issn 0022-1899Article

Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasisMURRAY, Henry W; MOREIRA, Andre L; LU, Cristina M et al.The Journal of infectious diseases. 2003, Vol 188, Num 3, pp 458-464, issn 0022-1899, 7 p.Article

Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasisMURRAY, Henry W; LU, Cristina M; BROOKS, Elaine B et al.Infection and immunity. 2003, Vol 71, Num 11, pp 6453-6462, issn 0019-9567, 10 p.Article

Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialSUNDAY, Shyam; AGRAWAL, G; RAI, Madhukar et al.BMJ. British medical journal (International ed.). 2001, Vol 323, Num 7310, pp 419-422, issn 0959-8146Article

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatmentMURRAY, Henry W; JUNGBLUTH, Achim; RITTER, Erika et al.Infection and immunity. 2000, Vol 68, Num 11, pp 6289-6293, issn 0019-9567Article

Advances in leishmaniasisMURRAY, Henry W; BERMAN, Jonathan D; DAVIES, Clive R et al.Lancet (British edition). 2005, Vol 366, Num 9496, pp 1561-1577, issn 0140-6736, 17 p.Article

New Treatment Approach in Indian Visceral Leishmaniasis : Single-Dose Liposomal Amphotericin B Followed by Short-Course Oral MiltefosineSUNDAR, Shyam; RAI, M; CHAKRAVARTY, J et al.Clinical infectious diseases. 2008, Vol 47, Num 8, pp 1000-1006, issn 1058-4838, 7 p.Article

Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasisMURRAY, Henry W; FLANDERS, Kathleen C; DONALDSON, Debra D et al.Infection and immunity. 2005, Vol 73, Num 7, pp 3903-3911, issn 0019-9567, 9 p.Article

Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapyMURRAY, Henry W; LU, Christina M; MAUZE, Smita et al.Infection and immunity. 2002, Vol 70, Num 11, pp 6284-6293, issn 0019-9567, 10 p.Article

Case Report: Non-Oral Treatment with Ivermectin for Disseminated StrongyloidiasisFUSCO, Dahlene N; DOWNS, Jennifer A; SATLIN, Michael J et al.The American journal of tropical medicine and hygiene. 2010, Vol 83, Num 4, pp 879-883, issn 0002-9637, 5 p.Article